Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention and management of major side effects of targeted agents in breast cancer.
Metzger Filho O, Saini KS, Azim HA Jr, Awada A; Association of Radiotherapy and Oncology of the Mediterranean arEa (AROME). Metzger Filho O, et al. Among authors: saini ks. Crit Rev Oncol Hematol. 2012 Dec;84 Suppl 1:e79-85. doi: 10.1016/j.critrevonc.2010.07.014. Epub 2011 Mar 15. Crit Rev Oncol Hematol. 2012. PMID: 20817545 Review.
Rituximab in Hodgkin lymphoma: is the target always a hit?
Saini KS, Azim HA Jr, Cocorocchio E, Vanazzi A, Saini ML, Raviele PR, Pruneri G, Peccatori FA. Saini KS, et al. Among authors: saini ml. Cancer Treat Rev. 2011 Aug;37(5):385-90. doi: 10.1016/j.ctrv.2010.11.005. Epub 2010 Dec 22. Cancer Treat Rev. 2011. PMID: 21183282 Review.
DNA methylation profiling reveals a predominant immune component in breast cancers.
Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, Lallemand F, Larsimont D, Toussaint J, Haussy S, Rothé F, Rouas G, Metzger O, Majjaj S, Saini K, Putmans P, Hames G, van Baren N, Coulie PG, Piccart M, Sotiriou C, Fuks F. Dedeurwaerder S, et al. EMBO Mol Med. 2011 Dec;3(12):726-41. doi: 10.1002/emmm.201100801. Epub 2011 Nov 16. EMBO Mol Med. 2011. PMID: 21910250 Free PMC article.
Dissecting the heterogeneity of triple-negative breast cancer.
Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Ellis P, Di Leo A, Baselga J, Sotiriou C, Piccart-Gebhart M. Metzger-Filho O, et al. Among authors: saini ks. J Clin Oncol. 2012 May 20;30(15):1879-87. doi: 10.1200/JCO.2011.38.2010. Epub 2012 Mar 26. J Clin Oncol. 2012. PMID: 22454417 Review.
Targeted therapies in breast cancer: are heart and vessels also being targeted?
Criscitiello C, Metzger-Filho O, Saini KS, de Castro G Jr, Diaz M, La Gerche A, de Azambuja E, Piccart-Gebhart MJ. Criscitiello C, et al. Among authors: saini ks. Breast Cancer Res. 2012 Jun 19;14(3):209. doi: 10.1186/bcr3142. Breast Cancer Res. 2012. PMID: 22713170 Free PMC article. Review.
Pertuzumab: new hope for patients with HER2-positive breast cancer.
Capelan M, Pugliano L, De Azambuja E, Bozovic I, Saini KS, Sotiriou C, Loi S, Piccart-Gebhart MJ. Capelan M, et al. Among authors: saini ks. Ann Oncol. 2013 Feb;24(2):273-282. doi: 10.1093/annonc/mds328. Epub 2012 Aug 21. Ann Oncol. 2013. PMID: 22910839 Free article. Review.
130 results